EMPA-Kidney in Context: Expanding Our Understanding of Sodium-Glucose Cotransporter 2 Inhibition in Chronic Kidney Disease Management

Did you know that nearly one third of patients with type 2 diabetes also have cardiovascular disease? Credit available for this activity expires: 12/28/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/985571?ecd=bdc_podcast_libsyn_mscpedu